|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:dateCreated |
2008-1-30
|
|
pubmed:abstractText |
The mechanism of Botulinum Toxin Type A (BTX-A) action at the neuromuscular junction is well known. But from the introduction of BTX-A, some authors have suggested a central action of BTX-A and possible side effects far from the site of injection. Some studies demonstrate an improvement of cortical SEPs associated with reduction of spasticity after BTX-A injection. The aim of the present study was to determine the effect of BTX-A treatment on cortical somatosensory potentials (SEP).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1896-1126
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
52 Suppl 1
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
171-5
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:18229658-Adolescent,
pubmed-meshheading:18229658-Botulinum Toxins, Type A,
pubmed-meshheading:18229658-Cerebral Cortex,
pubmed-meshheading:18229658-Cerebral Palsy,
pubmed-meshheading:18229658-Child,
pubmed-meshheading:18229658-Child, Preschool,
pubmed-meshheading:18229658-Evoked Potentials, Somatosensory,
pubmed-meshheading:18229658-Female,
pubmed-meshheading:18229658-Functional Laterality,
pubmed-meshheading:18229658-Humans,
pubmed-meshheading:18229658-Leg,
pubmed-meshheading:18229658-Male,
pubmed-meshheading:18229658-Muscle Spasticity,
pubmed-meshheading:18229658-Neuromuscular Agents,
pubmed-meshheading:18229658-Neuromuscular Junction
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Cortical somatosensory evoked potentials and spasticity assessment after botulinum toxin type A injection in children with cerebral palsy.
|
|
pubmed:affiliation |
Department of Pediatric Neurology and Rehabilitation, Medical University of Bia?ystok, Poland. bockow@kki.pl
|
|
pubmed:publicationType |
Journal Article
|
